Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GBF1 is a guanine nucleotide exchange factor (GEF) primarily for ADP-ribosylation factors (ARFs), which are small GTPases involved in vesicular trafficking. GBF1 is essential for maintaining Golgi architecture, facilitating secretion, and regulating the recruitment of proteins to membranes by mediating GDP-to-GTP exchange on ARFs. It plays roles in intracellular transport, Golgi apparatus maintenance, mitochondrial organization, viral replication, and host-pathogen interactions. Inhibitors like Brefeldin A and Golgicide A block its GEF activity by preventing GDP/GTP exchange on ARFs.
Inhibition of GDP-GTP exchange on ARFs
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brefeldin A-resistance guanine nucleotide exchange factor 1 (GBF1).